Universal Diagnostics
Biotechnology Research • 
Seville, Andalusia, Spain • 101-200 Employees
Company overview
| Headquarters | Avenida Diego Martínez Barrio, 10, Edificio Insur 3ª planta. Mod. 15, Sevilla, Andalucía 41013, ES |
| Phone number | +34955420154 |
| Website | |
| SIC | 873 |
| Keywords | Biotechnology, Diagnostics Tests, Early Detection Of Cancer, Metabolomic Biomarkers |
| Founded | 2012 |
| Employees | 101-200 |
| Socials |
Key Contacts at Universal Diagnostics
Celia Selmes
Hr Director
Marko Bitenc
Co Founder
Paola Hurtado
Senior Director Program Management, Operations And Product
Laura Deason
Director Study Startup And Site Maintenance
Pol Canal Noguer
Sr Director Of Data Science & Bioinformatics
Adam Flis
Director Of Engineering
Heidi Slocum
Director Of Pre-Analytical Development
Alfred Haddad
Director, Automation Development
Paty Lopez-Quispe
Sr Director Of Quality
Jamme Tan
Senior Director Of Production Engineering
Universal Diagnostics Email Formats
Universal Diagnostics uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@universaldx.com), used 51.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@universaldx.com | 51.5% |
{first initial}.{last name} | j.doe@universaldx.com | 35% |
{first initial}.{second initial} | j.o@universaldx.com | 7.8% |
{first initial}{last name} | jdoe@universaldx.com | 1.9% |
{first initial}.{first3} | j.{first3}@universaldx.com | 1.9% |
About Universal Diagnostics
Universal Diagnostics S.A. (UDX) is a Spanish in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early. The UDX diagnostic platform is designed to detect various cancer types, e.g. colorectal, prostate, liver, pancreatic lung, breast cancer (>50% of all new cancer cases p.a.) via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis. UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I). To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.
Universal Diagnostics revenue & valuation
| Annual revenue | $4,300,000 |
| Revenue per employee | $36,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $13,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Universal Diagnostics has 80 employees across 16 departments.
Departments
Number of employees
Funding Data
Universal Diagnostics has never raised funding before.
Universal Diagnostics Tech Stack
Discover the technologies and tools that power Universal Diagnostics's digital infrastructure, from frameworks to analytics platforms.
CDN
Analytics
CDN
JavaScript libraries
Tag managers
Miscellaneous
Security
Miscellaneous
Page builders
Analytics
Font scripts
United Kingdom
Netherlands
Italy
Frequently asked questions
4.8
40,000 users
